文献速递毛发、甲与色素性疾病皮肤肿瘤

乳腺癌患者接受紫杉类化疗及辅助激素治疗后的永久性脱发:10例临床病理分析

Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients.
PubMed 文献 · J Am Acad Dermatol · 2017-03-08

该研究回顾性分析了10例接受紫杉类化疗及辅助激素治疗的乳腺癌患者的临床与组织病理资料,观察到3种脱发临床模式(A、B、C型),并验证了斑秃样及女性型脱发的组织病理学特征。作者据此提出毛囊周期破坏的临床病理模型,认为化疗炎症与激素损伤可导致永久性脱发。

要点

  • 紫杉类化疗后脱发不一定可逆,需警惕永久性脱发。
  • 临床可表现为3种模式,组织病理呈斑秃样及女性型脱发特征。
  • 临床与病理对照有助于理解化疗相关脱发的生物学路径。

核心结论

  • 紫杉类化疗及辅助激素治疗可致毛囊周期破坏,从而引起永久性脱发。
  • 临床病理对照对理解化疗诱导脱发的形态生物学路径至关重要。

研究设计与样本

  • 回顾性队列研究,共纳入10例接受紫杉类及辅助激素化疗的乳腺癌患者。
  • 复习其临床与组织病理学信息,并对治疗后切片进行组织病理学复核。

主要发现

  • 观察到3种脱发临床模式(A型、B型、C型)。
  • 验证了斑秃样和女性型脱发的组织病理学特征。

临床怎么用

  • 对紫杉类化疗后持续脱发的乳腺癌患者应行临床与病理评估。
  • 需结合辅助激素治疗史判断脱发是否可能为永久性。

局限性

  • 样本量小。
  • 临床资料为回顾性获取,组织病理为治疗后切片的回顾性复核。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anagen effluvium with reversible scalp alopecia is a known side effect of chemotherapy. However, there are an increasing number of reports in the literature documenting permanent alopecia in patients treated with taxanes. OBJECTIVE: We sought to describe the clinicopathologic features in breast cancer patients who underwent treatment with taxanes and adjuvant hormonal chemotherapy. METHODS: We reviewed the clinical and histopathologic information of a cohort of 10 patients treated with taxanes and adjuvant hormonal chemotherapy. RESULTS: We have observed 3 types of clinical patterns of alopecia (types A, B, and C), and have validated the histopathologic features showing alopecia areata-like and female pattern hair loss. LIMITATIONS: The study was based on a small sample size and retrospective retrieval of clinical information and histopathologic review of posttreatment slides. CONCLUSIONS: We hypothesize a clinicopathologic model of hair follicle cycle disruption in response to the chemoinflammatory and hormonal insults to the hair follicles resulting in permanent alopecia. Clinicopathologic correlation is paramount to the understanding of the morphobiologic pathways in chemotherapy-induced alopecia caused by taxanes and adjuvant hormonal treatment.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Fonia A, Cota C, Setterfield JF, et al. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients. J Am Acad Dermatol. 2017. PMID: 28284826. doi:10.1016/j.jaad.2016.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。